Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision

Clene (NASDAQ:CLNN) said it plans to submit a new drug application to the U.S. Food and Drug Administration at the beginning ...
bilibili

每日冥想：无人声引导冥想_8（15分钟）Au8

『五音疗疾』经典连放，养心气疏肝气，放松心情，解郁息怒，释放压力，清心明目。情绪低落，胆小多疑失眠多梦，视物模糊，胸闷气短自我怀疑，消沉抑郁面色萎黄等可多听用。
Santé log

Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA

Investment was led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million ...
stocktitan

Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA

Clene raises $4 million from insiders and existing holders, extending its cash runway past a potential FDA accept-for-review decision on CNM-Au8 for ALS. Rhea-AI Sentiment reads the wording of the ...